In the context of the world still lacks the supply of Covid-19 vaccines, the local vaccine development plan becomes a trend in Asia.

Since April, Thailand wits serious NCOV infection, mainly due to Delta transformation, causing the health system to be pushed to the overload of the overload.

In order to reduce dependence on imported vaccines very scarce and increase supply for the country, Thai scientific gender has studied many vaccines, with three of the six potential types included in a clinical trial

Thai scientists have reported positive results for two vaccines being clinically tested as Chulacov-19, using MRNA technology, and NDV-HXP-S, using inactivated viral technology.

Baiya Sars-Cov-2 Vax 1, another Covid-19 Vaccine Candidate in Thailand, is expected to begin to be tested in the next month.

A jar of NDV-HXP-S vaccine, the potential Vaccine Covid-19 candidate is being clinically tested in Thailand.

Meanwhile, Taiwan Island on August 23 began putting into use vaccines produced by Medigen inland Group after more than a year of trials.

The vaccine medigen was approved for emergency use at the end of July caused many suspicious people, because it had not been clinically tested in the third stage.

In Korea, President Moon Jae-In seems to also put hope in the Domestic Covid-19 vaccine, when committing to providing all available support for the development process, even launching a valuable investment package

We will try our best to reach the leap, with the goal of becoming one of the 5 largest global vaccine manufacturers in 2025, the Korean President announced, adding that the vaccine would be one of three

About Korean assessment experts, one of the countries that possess the world's largest biological pharmaceutical production capacity and have exported 5.1 billion USD of this product last year, potentially becoming a big man

There are 7 Korean companies who are conducting a clinical trial of 4 Vaccine Covid-19 at different stages.

However, Dr. Jerome Kim, General Director of International Vaccine In Seoul, notes that most Korean people have been fully vaccinated.

In Japan, 4 domestic pharmaceutical companies are conducting a clinical trial of Covid-19 vaccine.

Start-up Biotechnology Anges is Japan's first company started clinical trial Vaccine Covid-19 in June 2020, followed by Shionogi pharmaceutical firm with a recombinant protein vaccine.

Meanwhile, Daiichi Sankyo, Japan's leading pharmaceutical company, aims to deploy Vaccine Covid-19 using their MRNA technology next year.

In India, Covaxin, Vaccine Covid-19 also uses the inactivated virus technology of Bharat Biotech, which is approved for emergency use from January, before being tested in the third stage.

The Indian Biotechnology Ministry on August 20 announced a second domestic Domestic Covid-19 vaccine with Zycov-D, produced by Zydus CADILA.

DNA vaccine puts into a specific antigen antigen an antigen-based DNA to start the immune response process.

India is also accelerating to develop additional Covid-19 vaccines, to quickly vaccinate 1.3 billion people and serve export targets.

At present, at least 15 Covid-19 vaccines are being developed in India at different stages.